Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multiple sclerosis and pregnancy: maternal considerations.
The Sphingosine 1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Post-Infarction Left Ventricular Remodeling in a Porcine Model of Ischemia-Reperfusion.
Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system.
Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses.
Prediction of response to interferon therapy in multiple sclerosis.
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.
Value of susceptibility-weighted imaging in acute hemorrhagic leukoencephalitis.
Lobular panniculitis and lipoatrophy of the thighs with interferon-ß1a for intramuscular injection in a patient with multiple sclerosis.
Patient's Perspective: Hard Lessons from a Long Hospital Stay.
Low-contrast multifocal visual evoked potentials: Identifying more shades of gray in MS.
Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration.
Cannabinoids in the management of difficult to treat pain.
[Side-effects of glucocorticosteroids in multiple sclerosis: a case report of a patient with global amnesia.]
Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis.
Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway.
Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation.
Validity and variability of the 5-repetition sit-to-stand test in patients with multiple sclerosis.
Lack of response to pulse cyclophosphamide in neuromyelitis optica: evaluation of 7 patients.
Structure of the first sphingosine 1-phosphate receptor.
Motor vehicle operation in the setting of multiple sclerosis with myelopathy: assessment, adaptive equipment, counseling, and cessation of driving.
The risk of smoking on multiple sclerosis: a meta-analysis based on 20,626 cases from case-control and cohort studies.
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies.
B cells and antibodies in multiple sclerosis pathogenesis and therapy.
Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis.
Clinical characteristics and outcome of multiple sclerosis in Korea: does multiple sclerosis in Korea really differ from that in the Caucasian populations?
Pages
« first
‹ previous
…
168
169
170
171
172
173
174
175
176
…
next ›
last »